Evidence map›Paper›PMID 33588905›Full record

ReviewItalian journal of pediatrics2021

Could nutritional supplements act as therapeutic adjuvants in COVID-19?

Giorgio Costagliola, Erika Spada, Pasquale Comberiati, Diego G Peroni

Open access · goldAbstract readReview
In one paragraph

Review in Italian journal of pediatrics, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed
7.5field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 51 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Review
  5. Article
  6. Review
  7. Review
  8. The Important Role of Interleukin-2 in COVID-19.Journal of immunology research · 2023
    Review
  9. Article
  10. The year 2021 in COVID-19 pandemic in children.Italian journal of pediatrics · 2022
    Review
  11. Review
  12. A comprehensive insight into current control of COVID-19: Immunogenicity, vaccination, and treatment.Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie · 2022
    Review
  13. Review
  14. Review
  15. Article
  16. Review
  17. Review
  18. Review
  19. Review
  20. Protective Action ofMaterials (Basel, Switzerland) · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Giorgio CostagliolaClinical and Experimental Medicine, Division of Pediatrics, University of Pisa, Via Roma 57, 56126, Pisa, PI, Italy.
Erika SpadaClinical and Experimental Medicine, Division of Pediatrics, University of Pisa, Via Roma 57, 56126, Pisa, PI, Italy.
Pasquale ComberiatiClinical and Experimental Medicine, Division of Pediatrics, University of Pisa, Via Roma 57, 56126, Pisa, PI, Italy.
Diego G PeroniClinical and Experimental Medicine, Division of Pediatrics, University of Pisa, Via Roma 57, 56126, Pisa, PI, Italy. diego.peroni@unipi.it.
University of Pisa · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe role of the immune system and inflammatory response in the pathogenesis of the severe manifestations of coronavirus disease 2019 (COVID-19) is well known. Currently, different therapies active on the immune system are used for the management of COVID-19. The involvement of the immune system also opens the opportunity for the use of nutritional supplements with antimicrobial and immunomodulatory activity. MAIN ASPECTS: Nutritional supplements with antimicrobial and immunomodulatory activity are promising therapeutic adjuvants for the treatment of COVID-19, and also for the prevention of viral spreading. In particular, the role of vitamin D, probiotics, lactoferrin, and zinc is of significant clinical interest, although there are only a few data on their use in COVID-19 patients. Their molecular actions, together with the results of studies performed on other respiratory infections, strongly suggest their potential utility in COVID-19. This article discusses the main properties of these nutritional supplements and their potential applicability in the prevention and treatment of COVID-19.

conclusionThe supplementation with vitamin D, probiotics, lactoferrin and zinc could have a role both in preventing SARS-CoV-2 infection and in mitigating the clinical course in infected patients, contributing in the prevention of immune-mediated organ damage.

Indexed as

COVID-19 Drug TreatmentDietary SupplementsCOVID-19HumansLactoferrinPandemicsProbioticsSARS-CoV-2Vitamin DZincLactoferrinVitamin DZincCOVID-19Cytokine stormImmune systemLactoferrinNutritionProbioticsSupplementationVitamin dZinc

Identifiers

PMID33588905
PMCPMC7883952
OpenAlexW3130198722

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.